Evaluation of Non-Compressive Myelopathy in a Sample of Egyptian Patients

Myelopathy Clinical Trial

Official title:

Evaluation of Non-Compressive Myelopathy in a Sample of Egyptian Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05257330
• Other study ID #: 0000044
• Status: Recruiting
• Start date: January 1, 2022
• Est. completion date: July 31, 2022

Study information

• Verified date: February 2022
• Source: Al-Azhar University
• Contact: Islam S Al-Emam, MSC
• Phone: +201027759946
• Email: eslamsalman211[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

An observational study will be conducted in the Department of Neurology at AlAzhar University Hospitals To study the etiological factors of non-compressive myelopathy in a sample of Egyptian patients

Description:

Myelopathy is a collective term referring to any pathologic condition or neurologic deficit related to the spinal cord. Myelopathies are a frequent and potentially disabling neurologic emergency.(Sarbu et al., 2019).

Diseases of the spinal cord often have devastating consequences and imaging studies are indispensable for their diagnosis. The diagnostic approach must be based on the clinical context, the time elapsed since the onset of symptoms and signs, and the imaging findings (Herrera et al., 2020).

Myelopathies may be compressive or non-compressive, regarding to subarachnoid space obstruction (Kundu et al., 2018).

Noncompressive myelopathy (NCM) is described as "spinal cord involvement without detectable clinical and radiological evidence of spinal cord compression causing neurological deficit (Thangaraj et al., 2019).

There have been a few studies that have investigated Noncompressive myelopathy (NCM) in Africa as part of nontraumatic myelopathy. With very few studies focusing on NMOSD, Most of them focus on extrinsic compression and infectious diseases as important causes of myelopathy (Musubire et al., 2021) Comprehensive data on Egyptian patients with Non-compressive myelopathy (NCM) in the light of newer diagnostic criteria and serological tests are lacking. No study has been conducted to study the clinico-radiological profile of Non-compressive myelopathy (NCM) so far. In this study, we are putting an effort to convey our experience on etiological pattern of Non-compressive myelopathy (NCM) with special reference to its radiological features.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: July 31, 2022
• Est. primary completion date: June 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 2 Months to 100 Years

Eligibility

Inclusion Criteria:

• Patients with acute, subacute, or chronic neurologic dysfunction (motor and sensory deficit, sphincteric involvement, and a well-defined upper sensory segmental level) consistent with myelopathy (with or without coexisting encephalopathy, neuropathy, or radiculopathy).

Exclusion Criteria:

• 1) Patients of myelopathy who did not undergo magnetic resonance imaging (MRI) of the spinal cord. 2) Spinal cord compression on MRI explaining patient's neurologic dysfunction. 3) History of previous trauma, acute coma and patients with definite cerebral symptoms incompatible with spinal pathology (e.g., aphasia, hemianopia, neglect, facial involvement). 4) Motor neuron disease (MND) 5)Degenerative ataxias.

Related Conditions & MeSH terms

• Bone Marrow Diseases
• Myelopathy
• Spinal Cord Diseases

Intervention

Diagnostic Test:
• CSF Examination
Lumbar puncture for CSF Examination

Locations

Country	Name	City	State
Egypt	Al-Hussein and Sayed Galal Hospitals	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Al-Azhar University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To study the etiological factors of non-compressive myelopathy in a sample of Egyptian patients	study the clinico-radiological profile of Non-compressive myelopathy	6 months